Cargando…
Effectiveness of Chinese medicine formula Huashibaidu granule on mild COVID-19 patients: A prospective, non-randomized, controlled trial
BACKGROUND: The effectiveness and safety of Huashibaidu granule (HSBD) in treating mild Corona Virus Disease 2019 (COVID-19) patients infected with SARS-CoV-2 remain to be identified. We aimed to evaluate the effectiveness of HSBD in mild COVID-19 patients. METHODS: A prospective, non-randomized, co...
Autores principales: | Chen, Bowu, Xue, Yan, Jing, Hua, Wang, Xiaodong, Zhu, Peimin, Hao, Weiwei, Li, Man, Gao, Yueqiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121152/ https://www.ncbi.nlm.nih.gov/pubmed/37192979 http://dx.doi.org/10.1016/j.imr.2023.100950 |
Ejemplares similares
-
Chinese Medicine Formula Huashibaidu Granule Early Treatment for Mild COVID-19 Patients: An Unblinded, Cluster-Randomized Clinical Trial
por: Zhao, Chen, et al.
Publicado: (2021) -
Clinical efficacy of Jingyin granules, a Chinese patent medicine, in treating patients infected with coronavirus disease 2019
por: Chen, Bowu, et al.
Publicado: (2023) -
Traditional Chinese Medicine JingYinGuBiao Formula Therapy Improves the Negative Conversion Rate of SARS-CoV2 in Patients with Mild COVID-19
por: Chen, Bowu, et al.
Publicado: (2022) -
The effect of Huashibaidu formula on the blood oxygen saturation status of severe COVID-19: A retrospective cohort study
por: Xiong, Yibai, et al.
Publicado: (2022) -
Huashibaidu formula attenuates sepsis-induced acute lung injury via suppressing cytokine storm: Implications for treatment of COVID-19
por: Zhang, Fangbo, et al.
Publicado: (2023)